Promoting predictive, preventive and personalized medicine in treatment of cardiovascular diseases

Obstructive sleep apnea: its prevention and screening may contribute to the prevention of hypertension, diabetes and cardiovascular diseases

(2011) Takeshi Tanigawa   EPMA Journal

Obstructive sleep apnoea as a risk factor for atherosclerosis – implication for preventive and personalised treatment

(2011) Izabela Tuleta et al.   EPMA Journal

Associations of impaired glucose metabolism and dyslipidemia with cardiovascular diseases: what have we learned from Japanese cohort studies for individualized prevention and treatment?

(2011) Yoshihiro Kokubo   EPMA Journal

Degenerative valve disease and bioprostheses: risk assessment, predictive diagnosis, personalised treatments

(2011) Kristina Yeghiazaryan et al.   EPMA Journal

Why we need integrative medicine

(2011) Paolo Roberti di Sarsina et al.   EPMA Journal

Stem cells therapy for cardiovascular repair in ischemic heart disease: How to predict and secure optimal outcome?

(2011) Jens Kastrup   EPMA Journal

Adiposity and risk of cardiovascular diseases in Japan: secular trend, individual level associations and causal pathway – implications for the prevention of cardiovascular diseases in societies with rapid economic development

(2011) Hiroshi Yatsuya et al.   EPMA Journal

Personalized cardiac regeneration by stem cells–Hype or hope?

(2011) Ulrich Marc Becher et al.   EPMA Journal

A Japanese health success story: trends in cardiovascular diseases, their risk factors, and the contribution of public health and personalized approaches

(2011) Hiroyasu Iso   EPMA Journal

Cardio-metabolic risk prediction should be superior to cardiovascular risk assessment in primary prevention of cardiovascular diseases

(2011) Hana Rosolova et al.   EPMA Journal

Epidemiology and prevention of hypertension in Japanese: how could Japan get longevity?

(2011) Katsuyuki Miura   EPMA Journal

The influence of sulforaphane on vascular health and its relevance to nutritional approaches to prevent cardiovascular disease

(2011) Paul C. Evans   EPMA Journal

Lipoprotein associated phospholipase A2: role in atherosclerosis and utility as a biomarker for cardiovascular risk

(2011) Kenneth J. Colley et al.   EPMA Journal